Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-23-004167

Options or other derivatives

  • Director bought 2,000,000 shares at $0.50 ($1,000,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
ZEN Wei Peu Director 2023-01-18 Purchase · Convertible Promissory Note dated 2023-01-18 +2,000,000 $0.50 $1,000,000 2,000,000 D
Loading xslF345X03/doc4.xml…